Clinical Trial Update: Mindfulness Training Plus Oxytocin Effects on Smoking Behavior [Phase 2, Phase 3]

View source ↗

Summary

A terminated Phase 2/Phase 3 trial evaluating the combination of mindfulness training and oxytocin for smoking behavior and cessation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University of Southern California | Conditions: Smoking, Smoking Cessation | Phase 2, Phase 3 | Status: TERMINATED